• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Science & Research

  • Print
  • Share
  • E-mail

Advancing Regulatory Science

 Moving Regulatory Science into the 21st Century


ARS Graphic

Regulatory Science is the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of all FDA-regulated products.

On February 24, 2010, FDA launched its Advancing Regulatory Science Initiative (ARS), building on the achievements of existing Agency programs, like the Critical Path Initiative's groundbreaking efforts to transform the way medical products are developed, evaluated, and manufactured. 

Recognizing the success of the Critical Path model, ARS is expanding its scope to encompass every dimension of regulatory science. The goals of the Advancing Regulatory Science Initiative, highlighted below, span the breadth of FDA's regulatory activities. 


Sign up for Good Clinical Practice/Human Subject Protection e-mail updates Sign up for the latest news on leading-edge scientific
 research, initiatives, and events at FDA


Strategic Plan for Regulatory Science

FDA has developed a strategic plan for regulatory science, the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products.

 

Cover of the Strategic Plan for Regulatory Science

 

Advancing Regulatory Science for Public Health

 

This document outlines a broad vision for advancing regulatory science and unleashing its potential to improve public health.

View speech by FDA Commissioner Margaret A. Hamburg, M.D. disclaimer icon
National Press Club, Oct. 6, 2010
 

link to FDA report Advancing Regulatory Science for Public Health

 

-

Regulatory Science Initiative Plan

-
-